Baillie Gifford & Co
KITE

Baillie Gifford & Co’s Kite Pharma, Inc. KITE Stock Holding History

Baillie Gifford & Co’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,754
Closed -$495K – 208
2017
Q3 		$495K Buy
2,754
+190
+7% +$26.5K ﹤0.01% 196
2017
Q2 		$266K Hold
2,564
– – ﹤0.01% 201
2017
Q1 		$201K Buy
+2,564
New +$159K ﹤0.01% 200

Baillie Gifford & Co's KITE Position: Q4 2017 in Review

Baillie Gifford & Co sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,754 shares — an estimated $495K sold.

Baillie Gifford & Co first reported a position in KITE in Q1 2017 and held it in 3 quarters. The position peaked at $495K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Baillie Gifford & Co reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Baillie Gifford & Co sold 2,754 Kite Pharma, Inc. shares in Q4 2017, an estimated $495K.
  • Baillie Gifford & Co first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 3 quarters.
  • Baillie Gifford & Co's Kite Pharma, Inc. position peaked at $495K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Baillie Gifford & Co's 13F filing for Q4 2017, filed 13 Feb 2018.